Bipolar 1 Disorder
Neurology·MeSH: Mania
Prevalence
463.1 / 100K
Incidence
32.5 / 100K/yr
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| rap-219 | Rapport Therapeutics, Inc. (RAPP) |
Preclinical(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Bipolar 1 Disorder?
BioSniper tracks 2 drugs in development for Bipolar 1 Disorder across 2 companies.
How many clinical trials target Bipolar 1 Disorder?
There are 2 clinical trials targeting Bipolar 1 Disorder tracked by BioSniper.
What is the prevalence of Bipolar 1 Disorder?
The estimated prevalence of Bipolar 1 Disorder is approximately 463.1 per 100,000 population.
Deep-dive into Bipolar 1 Disorder
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis